Galeno Research Unit

Galeno Research Unit (GRU) is a premier Clinical Research Organization (CRO) based in Mexico City, Mexico, providing comprehensive clinical trial management services. The company specializes in Phase I through IV studies for the global pharmaceutical and biotechnology industries, with a particular emphasis on bioequivalence and bioavailability testing. GRU operates a state-of-the-art bioanalytical laboratory equipped for complex pharmacokinetic and pharmacodynamic analyses. Their service portfolio includes regulatory affairs, pharmacovigilance, site management, and data management, all conducted under strict international quality standards such as Good Clinical Practice (GCP). By facilitating research in the Latin American market, GRU helps sponsors navigate local regulatory requirements while ensuring high-quality data collection and patient safety.